Both in Pharmaceuticals
Roivant Sciences vs ZOETIS
Over the past year ROIV returned +86.1% and ZTS returned −42.2%; their daily moves had a correlation of -0.01.
ROIV +86.1% ZTS −42.2%Growth of $1, one year, split-adjusted
| Metric | ROIV | ZTS |
|---|---|---|
| Price | $35.89 | $83.18 |
| Market cap | $25.92B | $34.37B |
| Today | −2.76% | +4.34% |
| 1 month | +0.5% | +19.4% |
| 6 months | +26.6% | −26.2% |
| Year to date | +65.4% | −33.9% |
| 1 year | +83.3% | −42.3% |
| Revenue growth (YoY) | −33.5% | −0.2% |
| Gross margin | 100.0% | 72.7% |
| Net margin | −13164.8% | 28.0% |
| P/E (TTM) | — | 13.1× |
| Price / sales | 3,441.9× | 3.6× |
| Net cash | $3.84B | -$7.37B |
| Dividend yield | — | 2.55% |
| Volatility (60d) | 49.1% | 29.2% |
| Short % of float | 8.0% | 4.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).